4Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional co- agulopathy in exsanguinating hemorrhage:a computer simulation. J Trauma,2003,54:454-463.
5Hardy JF, De Moerbose P, Samama M, et al. Massive transfusion and coagulopathy;pathophysiology and implications for clini- cal management. Can J Anesth,2004,51:293-310.
6Krause KR, Howells GA, Buhs CL, et al. Hypothermia-induced coagulopathy during hemorrhagic shock. Am Surg,2000,66: 348-354.
5Kashuk JL, Moore EE ,Wohlauer M ,et al. Initial experiences with point-of-carerapid thrombelastography for management of lifethreatening postinjury coagulopathy [J]. Transfusion, 2012,52(1):23-33.
6Levi M,FriesD,GombotzH,et al. Preven- tion and treatment of coagulopathy in pa- tients receiving massive transfusions[J].Vox Sang,2011,101(2) :154-174.
7Spinella P C ,Holcomb J B. Resuscitation and transfusion principles for traumatic hemorrhagic shock[J] (6) : 231-240. Blood Rev, 2009,23.
8Meyer MAS,Ostrowski SR,Windel NA,et al. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? [J]. Vox Sang,2011,101(3) :185-190.
9Sinha R,Roxby D.Transfusion practices in massive haemorrhage in preintensive and intensive care[J]. Vox Sanguinis,2011,101 (3) :230-236.
